InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in Virtual Investor Events Next Week
May 25, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at two upcoming investor events. The company announced that members of its executive team will be participating in the Tribe Public Webinar, slated for May 31, 2023, and the Investor Summit, scheduled […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Tower Research Fireside Chat
May 19, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at an upcoming Water Tower Research Fireside Chat Series. The company announced that CEO Eric A. Adams will be the featured speaker at the May 23, 2023, fireside chat; the event is […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update
May 15, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several […]
InvestorNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Receives IND Clearance from FDA, Represents First Ever Natural Killer Immunotherapy Trial for a Particular Cancer
May 8, 2023
INmune Bio (NASDAQ: INMB), a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease, announced that its Investigational New Drug (“IND”) application for INKmune(TM), a novel natural killer (“NK”) cell immunotherapy, has been cleared by the U.S. Food and Drug Administration (“FDA”) for a phase 1/2 open-label clinical trial […]
InvestorNewsBreaks – Endeavor Group Holdings Inc. (NYSE: EDR) Moves in Rare Opportunity to Form Global Live Sports and Entertainment Pureplay
April 3, 2023
Endeavor (NYSE: EDR), the parent company of UFC, was featured in a recent Fox Business article that discussed the company’s deal to acquire World Wrestling Entertainment Inc. (NYSE: WWE) from Vince McMahon and form a new public company. “Endeavor will hold a 51% controlling interest in the new company while WWE shareholders will have a […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Concludes Enrollment for Phase 2 Trial Studying INM-755 Cannabinol Cream
March 28, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has wrapped up enrollment for its previously announced phase 2 clinical trial, which is called INM-755-201-EB and designed to evaluate the use of its proprietary investigational drug INM-755 cannabinol (“CBN”); the cream is being studied for […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results Published
March 13, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has announced that results of its study have been published in the “International Journal of Molecular Sciences.” The study was designed to evaluate the anti-inflammatory effects of rare cannabinoids and their potential application for the treatment […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at Two March Investor Events
March 7, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, will be represented at two investor events in March: the Emerging Growth Conference and the VirtualInvestorConferences.com—Life Sciences Investor Forum. InMed CEO Eric A. Adams will present at both conferences. His presentation at the Emerging Growth Conference, […]
InvestorNewsBreaks – Sugarmade Inc. (SGMD) Moves to Create Dynamic New PubCo Targeting Hospitality, Entertainment and Multimedia Production Sectors
February 23, 2023
Sugarmade (OTC: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, today announced its entry into a binding letter of intent (“LOI”) to acquire the real estate assets and businesses of Treasure Mountain Holdings, LLC and Victorville Treasure Holdings, LLC. Management believes that the full resolution of this strategic […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report
February 21, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook
January 10, 2023
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as […]
InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Releases Financial Report for Q2, First Half of 2022
January 3, 2023
Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, as well as an operator of mobile games and augmented reality (“AR”) education curricula and products in China, is reporting unaudited financial results. The results are for the second quarter 2022, or the three months ended […]
InvestorNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Planned Spinoff of SRM Entertainment Inc.
December 19, 2022
Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced that SRM Entertainment has filed a registration statement with the Securities and Exchange Commission to separate the company. Upon completion of the spinoff, SRM and Jupiter Wellness will operate as two independent and separate public companies, with Jupiter Wellness expected […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results
December 16, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2022 annual meeting. The meeting of shareholders was held Dec. 15, 2022. During the meeting, shareholders considered and voted on all matters outlined in InMed’s notice of meeting and […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Officer, Changes Auditor
December 13, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announced that Jonathan Tegge, a member of Brio Financial Group, will shoulder the role of interim CFO effective Dec. 12, 2022. The announcement accompanied the news that InMed has signed a service contract with Brio Financial Group […]
InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Completion of Shengruihao Acquisition
November 28, 2022
Blue Hat (NASDAQ: BHAT) recently announced that Fujian Blue Hat Group Co. Ltd, a wholly owned subsidiary, has acquired 100% equity interests of Xiamen Shengruihao Technology Co. Ltd., a company specialized in product supply chain services and integrated enterprise services. “I am glad to announce that the company has completed the acquisition of Shengruihao through […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
November 22, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale of 1,818,185 INM common shares, which were issued at a purchase price of $3.30 per share (or prefunded warrant in […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
November 18, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller
November 17, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has named Sarah Li as vice president of accounting and InMed controller; the change will be effective Nov. 20, 2022. Li is replacing Brenda Edwards, who has been serving as interim chief financial officer for the […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor
November 16, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has unveiled a new neurodegenerative disease program (“INM-900 series”). The program will focus on studying the effects of cannabinoid analogs in neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. Prior to this announcement, InMed had identified […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update
November 14, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report included updates on the company’s pharmaceutical development programs, including INM-755 for the treatment of epidermolysis bullosa (“EB”) and INM-088 for […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event
November 10, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week
October 26, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. Epidermolysis Bullosa Global Awareness Week is Oct. 25-31, 2022. “In severe cases of epidermolysis bullosa, or EB, the very […]
Crypto Fest 2022 Gears Up for Networking and Entertainment for the Crypto-Defi-NFT-Web3 Community
September 26, 2022
The 4th edition of the Crypto Fest 2022 is being held on September 30, 2022, as a hybrid event in Cape Town, South Africa, and via live stream. Enthusiasts, businesses, and traders all over the world looking forward to the event can participate virtually. The Crypto Fest, in collaboration with the SA Innovation Summit, the largest […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces 2022 Financial Results, Business Update
September 23, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. “In the final quarter of our fiscal 2022, as well as throughout the previous fiscal year, we have made important advancements in our pharmaceutical […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Release FY 2022 Financial Report, Corporate Update
September 20, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, will be releasing its financial report for fiscal year 2022, the period ended June 30, 2022, later this month. The company has announced that it will release the financial report, along with business highlights, on Sept. 23, 2022. In addition, […]
InvestorNewsBreaks – PIXELYNX Announces Key Partnership with Entertainment Executive, Visual Effects Pioneer
September 16, 2022
PIXELYNX, the music metaverse gaming platform founded by groundbreaking electronic musicians and technology visionaries Joel Zimmerman, aka deadmau5, and Richie Hawtin, aka Plastikman, has partnered with producer Ed Ulbrich, a pioneer in the visual effects space. Named by “Fast Company” magazine as one of the 100 most creative people in the business, Ulbrich will serve as […]
PIXELYNX Names Entertainment Executive and Visual Effects Pioneer Ed Ulbrich as Strategic Partner
September 15, 2022
LONDON and LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) — via InvestorWire – PIXELYNX, the music metaverse™ gaming platform founded by groundbreaking electronic musicians and technology visionaries Joel Zimmerman aka deadmau5 and Richie Hawtin aka Plastikman, announced today that producer and visual effects pioneer Ed Ulbrich has signed on as a strategic partner and advisor to the company. Ulbrich produced the epic sci-fi […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $6M Private Placement Agreement
September 14, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has closed on a private placement agreement with two healthcare-focused institutional investors. The agreement consisted of the issue and sale of 691,245 of INM common shares prices at $8.68 per share (or prefunded warrant in lieu thereof), totaling approximately $6 […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters into $6M Securities Purchase Agreement
September 12, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has announced a private placement agreement with two healthcare-focused institutional investors. The agreement calls for the issuance and sale of 691,245 of INM common shares; the shares will be sold at a purchase price of $8.68 per share in a […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Update on Company Objectives and Programs
September 9, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting an update on the company’s research/development and commercial activities. According to the update, the company is working to complete enrollment in a phase 2 clinical program in epidermolysis bullosa (‘EB’) by the end of 2023, […]
InvestorNewsBreaks – Coinbase Global Inc. (NASDAQ: COIN) Collaborates with Integrated Gaming Entertainment Company
September 8, 2022
Coinbase (NASDAQ: COIN), one of the world’s largest cryptocurrency platforms and a trusted leader in the Web3 space, has entered a strategic collaboration with Enthusiast Gaming Holdings Inc. (NASDAQ: EGLX) (TSX: EGLX), an integrated gaming entertainment company. Under the partnership, Coinbase will provide developer tools, educational content and community-building support to power Enthusiast Gaming’s portfolio […]
InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Joint Agreement, Expanded Opportunity in Overseas Gaming Market
September 6, 2022
Blue Hat (NASDAQ: BHAT) today announced its entry into an agreement with a leading game distributor, Xiamen Traveler Network Technology Co. Ltd. (“TravelerNetwork”). Under the joint operating agreement, TravelerNetwork will distribute Blue Hat’s proprietary games “cute monopoly” and “cute game box” worldwide. According to management commentary provided in the news release, “TravelerNetwork has excellent global […]
InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters MOU to Acquire 100% Equity of Shengruihao
August 26, 2022
Blue Hat (NASDAQ: BHAT) today announced that its wholly owned subsidiary, Xiamen Duwei Consulting Management Co. Ltd, entered into a memorandum of understanding (“MOU”) with its shareholder of Xiamen Shengruihao Technology Co. Ltd. (“Shengruihao”) to acquire 100% of the equity interests of Shengruihao, a company specialized in product supply chain and integrated enterprise services. “I […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Board Appointment, Changes
August 9, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the appointment of Nicole Lemerond to its board of directors, effective immediately. Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. Throughout her career, she […]
InvestorNewsBreaks – Veritone Inc. (NASDAQ: VERI) Announces Continued Support for AWS Media & Entertainment Initiative
August 8, 2022
Veritone (NASDAQ: VERI), creator of aiWARE(TM), a hyper-expansive enterprise artificial intelligence (“AI”) platform, has announced an extension of its work with Amazon (NASDAQ: AMZN) and Amazon Web Services (“AWS”) to support its Media & Entertainment (“M&E”) customers. According to the update, Veritone last year joined the AWS for M&E initiative that helped content creators, rights […]
InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) New Business Strategy Game Enables Players to Become Millionaires
August 5, 2022
Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, and an operator of mobile games and augmented reality (“AR”) education curricula and products in China, is planning the release of a new game. The company has created a simulated business strategy game, called Cute Monopoly; […]
InvestorNewsBreaks – Sanwire Corporation (SNWR) Subsidiary Inks Agreement with Litco Entertainment to Create Urban Music Label
July 26, 2022
Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment space, through its wholly owned subsidiary, Intercept Music, has entered into a multiyear marketing and distribution partnership deal with Litco Entertainment. With offices in the United States, Mexico and Brazil, Litco is a global leader in urban marketing. The company has […]
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial
July 25, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the […]
InvestorNewsBreaks – Sycamore Entertainment Group Inc. (SEGI) Featured in Bell2Bell Podcast
July 21, 2022
Sycamore Entertainment Group (OTC: SEGI), a diversified entertainment company, was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Edward Sylvan, co-founder and CEO of Sycamore Entertainment Group, joined the latest episode to provide an introduction to the company and discuss its business […]